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the gastroc-soleus complex and a return to high-level 
physical activities; the incidence of re-rupture should not 
be considered as the main outcome.8
In clinical practice, an increasing number of patients 
managed non-surgically have no re-rupture, but the 
healed Achilles tendon has elongated, thus altering its 
relationship with the gastroc-soleus muscle complex.9 
These patients present with a more acute Achilles tendon 
resting angle,9 are not able to push off properly, and 
behave similarly to patients with chronic Achilles tendon 
rupture. Reconstructive surgery to correct this condition 
is possible,10 but it is more technically demanding than 
primary repair procedures, and probably much more 
expensive.
The musculoskeletal system thrives under load and 
motion, not immobilisation. Weight-bearing with 
functional bracing, which was originally developed for 
use after surgical management of acute Achilles tendon 
tears11 and has been used in more than 1000 patients 
in the past 20 years, is at least as good as plaster 
cast immobilisation for patients being managed 
conservatively, and, as shown by the UKSTAR trial, 
probably cheaper. At this point, we should explore 
whether the application of other strat egies could 
improve outcomes. For example, electrical stimulation 
of the gastroc-soleus complex could be introduced in the 
early phase of management of Achilles tendon rupture, 
together with isometric contractions of the same muscle 
group. Eccentric exercises might also be beneficial. 
Communication between orthopaedic sur geons, muscle 
physiologists, and rehabilitation specialists would greatly 
benefit patients with acute Achilles tendon ruptures.
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In 2015, the UK’s All-Party Parliamentary Group on 
Global Health (APPG) mapped the UK’s contribution 
to health globally, showing that it had world-class 
universities and research, was a global leader in health 
policy and international development, had strong life 
sciences and biomedical and biotech industries, and had 
a vibrant and diverse not-for-profit sector.1
In 2019, the APPG looked at what had changed in the 
intervening time and in the context of understanding 
the likely impact of Brexit on the UK’s global role 
in health. We gathered data from published and 
unpublished sources and interviewed 78 health and 
academic leaders—half from the UK and half from 
other countries—about their perceptions of the UK’s 
current and potential future role. On Feb 6, 2020, the 
APPG publishes its new report, The UK as a Global Centre 
for Health and Health Science.2
There have been considerable improvements in the 
past 5 years with, for example, big increases in funding 
for research, new regional collaborations between 
universities and National Health Service (NHS) bodies, 
and increased foreign investment in UK life sciences. 
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Published Online 
February 5, 2020 
https://doi.org/10.1016/
S0140-6736(20)30236-1
Comment
www.thelancet.com   Vol 395   February 8, 2020 399
There have also been advances in genomics, mental 
health, artificial intelligence, and other areas.
The health and academic leaders from outside the UK 
who were interviewed saw the UK as a force for good in 
health in the world. They commented positively on the 
UK’s track record in improving health globally and on its 
values, scientific and business standards, the strengths of 
its institutions, and its achievements in health and health 
science. They were, however, concerned about the UK 
becoming more inward looking and neglecting its global 
contribution, particularly at a time when other countries 
were already becoming more insular and protectionist. 
The UK health leaders largely had similar views and raised 
concerns about the potential loss of access to European 
collaboration and funding and the problems in staffing 
health services and research institutions.
Our new report proposes that the UK now needs to 
act decisively to maintain and strengthen its role as 
a global leader in health and health science.2 The UK 
must grasp the many opportunities represented by the 
fast-growing health and health sciences sectors and 
at the same time recognise, plan for, and mitigate the 
difficulties and risks.
Our vision is for the UK to become a global centre for 
health and health science, a go-to place for all aspects 
of health globally. We propose a two-part strategy 
that maintains the UK’s position as a trusted leader in 
health, with high standards and strong values, and at 
the same time invests in further development in and 
greater collaboration between all the UK organisations 
working in health and health science. The two parts of 
the strategy are shown in the panel.
The timing is perfect. The health sector is growing fast, 
science and technology promise new breakthroughs, 
and the UK has a well established core of expertise and 
institutions that are able, given the right support, to 
take advantage of them.
The new APPG report2 makes 12 recommendations 
that address both the risks and the opportunities. 
Two are highlighted here. The first recommendation 
emphasises the importance of international partnerships 
and global solidarity in tackling health globally. This 
is not a zero-sum game. The APPG recommends 
that the UK should further strengthen and develop 
its existing global partnerships, collaborations, and 
networks with international organisations, partners in 
high-income countries, and the fast-growing economies 
that are working to develop their health systems, as 
well as continuing to support low-income countries to 
improve the health of their populations. The second 
recommendation focuses on the importance of 
supporting and developing regional UK collaborations 
and institutions. It recognises the as yet untapped 
potential for growth and development, particularly 
in the Northern Health Sciences Alliance, Edinburgh 
BioQuarter, Life Sciences Hub Wales, GW4 Alliance in 
southwest England and southeast Wales, and MedCity 
in the southeast of England.
The UK is well known as a world financial sector. 
We believe it has the potential to be equally well known 
as a global centre for health and health science.
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Panel: The UK as a go-to place for health globally
The UK needs to act decisively to seize the opportunities and 
manage the risks. We propose that it should: 
1 Re-state its commitment to improving health globally, 
advocating for the right to health for all people 
everywhere, and working to the highest standards in 
science, business, and partnerships.
2 Bring together the combined strengths of its academic, 
government, commercial, and not-for-profit sectors to 
realise synergies and create a shared vision for the UK as a 
global centre for health and health science.  
For more on the Northern 
Health Sciences Alliance see 
https://www.thenhsa.co.uk/
For more on the Edinburgh 
BioQuarter see https://
edinburghbioquarter.com/
For more on the Life Sciences 
Hub Wales see https://
lshubwales.com/
For more on the GW4 Alliance 
see https://gw4.ac.uk/
For more on MedCity see 
https://www.medcityhq.com
